Quality of Life in Younger Leukemia and Lymphoma Survivors

NCT00956475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2011-08-24

No results posted yet for this study

Summary

RATIONALE: Collecting information about the effect of hematologic cancer and its treatment on quality of life may help doctors learn more about the disease and plan the best treatment.

PURPOSE: This phase I trial is studying quality of life in younger leukemia and lymphoma survivors.

Conditions

  • Anxiety Disorder
  • Cancer Survivor
  • Fatigue
  • Leukemia
  • Long-term Effects Secondary to Cancer Therapy in Adults
  • Lymphoma
  • Lymphoproliferative Disorder
  • Pain
  • Psychosocial Effects of Cancer and Its Treatment
  • Small Intestine Cancer

Interventions

BEHAVIORAL

telephone-based intervention

Patients are assessed in a telephone interview using a brief demographic and clinical data form. Patients then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.

OTHER

questionnaire administration

Patients are assessed in a telephone interview using a brief demographic and clinical data form. Patients then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.

PROCEDURE

assessment of therapy complications

questionnaire via telephone

PROCEDURE

fatigue assessment and management

questionnaire via telephone

PROCEDURE

psychosocial assessment and care

questionnaire via telephone

PROCEDURE

quality-of-life assessment

questionnaire via telephone

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Regan Demshar, RN · Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-09-30
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00956475 on ClinicalTrials.gov